Coherus Oncology
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CHRS and other ETFs, options, and stocks.About CHRS
Coherus Oncology, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of biosimilar therapeutics. Its products include UDENYCA and LOQTORZI.
CHRS Key Statistics
Stock Snapshot
Coherus Oncology(CHRS) stock is priced at $0.86, giving the company a market capitalization of 118.87M. It carries a P/E multiple of -0.75.
On 2026-11-07, Coherus Oncology(CHRS) stock moved within a range of $0.74 to $0.88. With shares now at $0.86, the stock is trading +17.0% above its intraday low and -1.3% below the session's peak.
Trading activity shows a volume of 1.08M, compared to an average daily volume of 2.06M.
The stock's 52-week range extends from a low of $0.73 to a high of $2.62.
The stock's 52-week range extends from a low of $0.73 to a high of $2.62.
Analyst ratings
83%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.